Janus Henderson Group’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,411,154
| Closed | -$3.81M | – | 2479 |
|
|
2022
Q3 | $3.81M | Buy |
1,411,154
+481,198
| +52% | +$1.3M | ﹤0.01% | 1068 |
|
|
2022
Q2 | $4.46M | Buy |
929,956
+409,193
| +79% | +$1.96M | ﹤0.01% | 864 |
|
|
2022
Q1 | $2.12M | Buy |
520,763
+395,610
| +316% | +$1.61M | ﹤0.01% | 1209 |
|
|
2021
Q4 | $857K | Buy |
+125,153
| New | +$857K | ﹤0.01% | 1579 |
|